ALKEM Alkem Laboratories Ltd Expansion Plans Announcement 2024 - Licensing Agreement Signed Alkem Laboratories has signed a licensing agreement with Sonnet BioTherapeutics to develop and commercialize the drug SON-080 for diabetic peripheral neuropathy in India, which has shown promising results in early trials..Find Corporate Announcements for Press Releases, AGM, Insider Trading & SAST, Results and Corporate Action for Alkem Laboratories Ltd